Cargando…
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813708/ https://www.ncbi.nlm.nih.gov/pubmed/36603522 http://dx.doi.org/10.1016/j.esmoop.2022.100749 |
_version_ | 1784863978146496512 |
---|---|
author | Overbeek, J.K. Heine, R. ter Verheul, H.M.W. Chatelut, E. Rudek, M.A. Gurney, H. Plummer, R. Gilbert, D.C. Buclin, T. Burger, D.M. Bloemendal, H.J. van Erp, N.P. |
author_facet | Overbeek, J.K. Heine, R. ter Verheul, H.M.W. Chatelut, E. Rudek, M.A. Gurney, H. Plummer, R. Gilbert, D.C. Buclin, T. Burger, D.M. Bloemendal, H.J. van Erp, N.P. |
author_sort | Overbeek, J.K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9813708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98137082023-01-06 Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs Overbeek, J.K. Heine, R. ter Verheul, H.M.W. Chatelut, E. Rudek, M.A. Gurney, H. Plummer, R. Gilbert, D.C. Buclin, T. Burger, D.M. Bloemendal, H.J. van Erp, N.P. ESMO Open Editorial Elsevier 2023-01-03 /pmc/articles/PMC9813708/ /pubmed/36603522 http://dx.doi.org/10.1016/j.esmoop.2022.100749 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Editorial Overbeek, J.K. Heine, R. ter Verheul, H.M.W. Chatelut, E. Rudek, M.A. Gurney, H. Plummer, R. Gilbert, D.C. Buclin, T. Burger, D.M. Bloemendal, H.J. van Erp, N.P. Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs |
title | Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs |
title_full | Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs |
title_fullStr | Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs |
title_full_unstemmed | Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs |
title_short | Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs |
title_sort | off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813708/ https://www.ncbi.nlm.nih.gov/pubmed/36603522 http://dx.doi.org/10.1016/j.esmoop.2022.100749 |
work_keys_str_mv | AT overbeekjk offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT heinerter offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT verheulhmw offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT chatelute offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT rudekma offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT gurneyh offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT plummerr offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT gilbertdc offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT buclint offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT burgerdm offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT bloemendalhj offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs AT vanerpnp offlabelbutontargettheevidenceneededtoimplementalternativedosingregimensofanticancerdrugs |